VICKI NIGAM: Open Payments
NPI 1730679804 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 42 payments from 16 companies in 2025. Trend: 2023 $674 · 2024 $1,157 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $166 |
| Amgen Inc. | 5 | $102 |
| PFIZER INC. | 5 | $95 |
| Seqirus USA Inc | 2 | $59 |
| Lilly USA, LLC | 3 | $57 |
| Exact Sciences Corporation | 2 | $51 |
| Novo Nordisk Inc | 2 | $44 |
| Abbott Laboratories | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $38 |
Products named: QULIPTA, KRYSTEXXA, UBRELVY, PREVNAR 20, Flucelvax, The Cologuard Plus Collection Kit, FREESTYLE LIBRE 3, JARDIANCE.
Industry payments across WI — which companies pay providers there.
